Current OCT (optical coherence tomography) is too expensive to be used in the screening of patients who are at risk for diseases of the retina (>400M patients)
Lumedica Vision has developed technology that enables it to manufacture and sell an OCT system for 1/3 the market price
The OCT module design and manufacturing processes are technically mature, which significantly de-risks the investment to develop an ophthalmic instrument system